Inflammatory Cytokine Gene Expression in Mesenteric Adipose Tissue during Acute Experimental Colitis

BACKGROUND: Production of inflammatory cytokines by mesenteric adipose tissue (MAT) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Animal models of colitis have demonstrated inflammatory changes within MAT, but it is unclear if these changes occur in isolation or as part of a systemic adipose tissue response. It is also unknown what cell types are responsible for cytokine production within MAT. The present study was designed to determine whether cytokine production by MAT during experimental colitis is depot-specific, and also to identify the source of cytokine production within MAT. METHODS: Experimental colitis was induced in 6-month-old C57BL/6 mice by administration of dextran sulfate sodium (2% in drinking water) for up to 5 days. The induction of cytokine mRNA within various adipose tissues, including mesenteric, epididymal, and subcutaneous, was analyzed by qRT-PCR. These adipose tissues were also examined for histological evidence of inflammation. The level of cytokine mRNA during acute colitis was compared between mature mesenteric adipocytes, mesenteric stromal vascular fraction (SVF), and mesenteric lymph nodes. RESULTS: During acute colitis, MAT exhibited an increased presence of infiltrating mononuclear cells and fibrotic structures, as well as decreased adipocyte size. The mRNA levels of TNF-α, IL-1β, and IL-6 were significantly increased in MAT but not other adipose tissue depots. Within the MAT, induction of these cytokines was observed mainly in the SVF. CONCLUSIONS: Acute experimental colitis causes a strong site-specific inflammatory response within MAT, which is mediated by cells of the SVF, rather than mature adipocytes or mesenteric lymph nodes

Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review

The treatment of COVID-19 is particularly critical in pregnant women, considering the potential teratogenic effects of antiviral agents and the immune-depression related with pregnancy. The aim of this review is to systematically examine the current evidence on the clinical use of convalescent plasma during pregnancy. The electronic databases Medline PubMed Advanced Search Builder, Scopus, Web Of Science and Google Scholar were searched (until 1 January 2021). Inclusion criteria were pregnant women with COVID-19 (or SARS-CoV-2 infection), in whom convalescent plasma (or hyperimmune plasma) was used as treatment. We searched clinical trial registries (censored 5 January 2021) for eligible studies under way. After elimination of duplications, the initial search yielded 79 potentially relevant records, of which 67 were subsequently excluded. The 12 remaining records were case reports involving 12 pregnancies. Six of the mothers were reported to be well, two were reported to have preeclampsia, and in one case each the maternal outcome was described as survival, clinical improvement, discharged with oxygen and rehabilitation. With regard to the neonates, two were declared to be well, four had transient morbidity, two were critically ill and one died; normal ongoing pregnancies, but no post-delivery information, were reported for the remaining three cases. Clinical trials under way or planned to investigate the use of convalescent plasma for COVID-19 during pregnancy are lacking. This is the first systematic review of the literature regarding the treatment of COVID-19 in pregnancy. The published literature data seem to indicate that convalescent plasma administered to pregnant women with severe COVID-19 provides benefits for both the mother and the fetus. The quality of the available studies is, however, very limited since they are all case reports and thus suffer from relevant reporting bias

Electropolymerized molecularly imprinted polypyrrole film for dimethoate sensing: investigation on template removal after the imprinting process

The development of ultrasensitive analytical detection methods for organophosphorus pesticides such as dimethoate (DMT) plays a key role in healthy food production. DMT is an inhibitor of acetylcholinesterase (AChE), which can lead to the accumulation of acetylcholine and result in symptoms related to the autonomous and central nervous systems. Herein, we report the first spectroscopic and electrochemical study on template removal after an imprinting process from a polypyrrole-based molecularly imprinted polymer (PPy-MIP) film for the detection of DMT. Several template removal procedures were tested and evaluated using X-ray photoelectron spectroscopy. The most effective procedure was achieved in 100 mM NaOH. The proposed DMT PPy-MIP sensor exhibits a limit of detection of (8 +/- 2) x 10(-12) M

Water-Based Conductive Ink Formulations for Enzyme-Based Wearable Biosensors

Herein, this work reports the first example of second-generation wearable biosensor arrays based on a printed electrode technology involving a water-based graphite ink, for the simultaneous detection of l-lactate and d-glucose. The water-based graphite ink is deposited onto a flexible polyethylene terephthalate sheet, namely stencil-printed graphite (SPG) electrodes, and further modified with [Os(bpy)2(Cl)(PVI)10] as an osmium redox polymer to shuttle the electrons from the redox center of lactate oxidase from Aerococcus viridans (LOx) and gluocose oxidase from Aspergillus niger (GOx). The proposed biosensor array exhibits a limit of detection as low as (9.0 ± 1.0) × 10−6 m for LOx/SPG-[Os(bpy)2(Cl)(PVI)10] and (3.0 ± 0.5) × 10−6 m for GOx/SPG-[Os(bpy)2(Cl)(PVI)10], a sensitivity as high as 1.32 uA mm−1 for LOx/SPG-[Os(bpy)2(Cl)(PVI)10] and 28.4 uA mm−1 for GOx/SPG-[Os(bpy)2(Cl)(PVI)10]. The technology is also selective when tested in buffer and artificial sweat and is endowed with an operational/storage stability of ≈80% of the initial signal retained after 20 days. Finally, the proposed array is integrated in a wristband and successfully tested for the continuous monitoring of l-lactate and d-glucose in a healthy volunteer during daily activity. This is foreseen as a real-time wearable device for sport-medicine and healthcare applications

Water‐Based Conductive Ink Formulations for Enzyme‐Based Wearable Biosensors

Abstract Herein, this work reports the first example of second‐generation wearable biosensor arrays based on a printed electrode technology involving a water‐based graphite ink, for the simultaneous detection of l‐lactate and d‐glucose. The water‐based graphite ink is deposited onto a flexible polyethylene terephthalate sheet, namely stencil‐printed graphite (SPG) electrodes, and further modified with [Os(bpy)2(Cl)(PVI)10] as an osmium redox polymer to shuttle the electrons from the redox center of lactate oxidase from Aerococcus viridans (LOx) and gluocose oxidase from Aspergillus niger (GOx). The proposed biosensor array exhibits a limit of detection as low as (9.0 ± 1.0) × 10−6 m for LOx/SPG‐[Os(bpy)2(Cl)(PVI)10] and (3.0 ± 0.5) × 10−6 m for GOx/SPG‐[Os(bpy)2(Cl)(PVI)10], a sensitivity as high as 1.32 μA mm−1 for LOx/SPG‐[Os(bpy)2(Cl)(PVI)10] and 28.4 μA mm−1 for GOx/SPG‐[Os(bpy)2(Cl)(PVI)10]. The technology is also selective when tested in buffer and artificial sweat and is endowed with an operational/storage stability of ≈80% of the initial signal retained after 20 days. Finally, the proposed array is integrated in a wristband and successfully tested for the continuous monitoring of l‐lactate and d‐glucose in a healthy volunteer during daily activity. This is foreseen as a real‐time wearable device for sport‐medicine and healthcare applications

Adipose tissue inflammation during acute colitis.

<p>(A) Colons and adipose tissue [mesenteric (MAT), epididymal (EAT), and subcutaneous (SAT)] from mice sacrificed at Day 0 and Day 7 (<i>n</i> = 4 per timepoint) were analyzed for relative mRNA expression of TNF-α, IL-1β, and IL-6. Target gene expression was normalized to HPRT gene expression; fold change was calculated relative to mean SAT expression at Day 0. Data represent mean ± SD. ***<i>P</i><0.001, **<i>P</i><0.01, *<i>P</i><0.05 vs. Day 0 of the same tissue; †††<i>P</i><0.001, ††<i>P</i><0.01 vs. EAT and SAT at Day 7; ###<i>P</i><0.001 vs. MAT at Day 7. (B) H&E stained sections of formalin-fixed MAT, EAT, and SAT from Day 0 and Day 7 of experimental colitis were compared (<i>n</i> = 5 per time point). Representative images are shown (original magnification × 400; arrowhead  =  mononuclear infiltrates; thick arrow  =  fibrotic connective tissue; thin arrow  =  adipocytes).</p

Development and progression of experimental colitis.

<p>Male, 6 month-old C57BL/6 mice (<i>n</i> = 20) were exposed to 2% DSS in drinking water for up to 5 days. Mice were sacrificed at Day 0, 3, 7, and 14 of the experimental period (<i>n</i> = 5 per time point). (A) Daily body weight of mice sacrificed at Day 14; mice sacrificed at earlier time points followed a similar pattern. <i>*P</i><0.05 compared to initial body weight on Day 0. (B) Disease Activity Index (DAI) was calculated at the time of sacrifice based on weight loss, stool blood, and stool consistency. (C) Colons were excised and measured lengthwise. (D) H&E stained sections were graded for Histologic Severity Score. (E) Representative images of colon histology on Day 0, 3, 7, and 14 (original magnification × 100; arrowhead  =  mononuclear infiltrates, thick arrow  =  mucosal ulceration, thin arrow  =  epithelial hyperplasia). Data represent mean ± SD, <i>***P</i><0.001, <i>*P</i><0.05 vs. Day 0.</p

Inflammatory Cytokine Gene Expression in Mesenteric Adipose Tissue during Acute Experimental Colitis

BACKGROUND: Production of inflammatory cytokines by mesenteric adipose tissue (MAT) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Animal models of colitis have demonstrated inflammatory changes within MAT, but it is unclear if these changes occur in isolation or as part of a systemic adipose tissue response. It is also unknown what cell types are responsible for cytokine production within MAT. The present study was designed to determine whether cytokine production by MAT during experimental colitis is depot-specific, and also to identify the source of cytokine production within MAT. METHODS: Experimental colitis was induced in 6-month-old C57BL/6 mice by administration of dextran sulfate sodium (2% in drinking water) for up to 5 days. The induction of cytokine mRNA within various adipose tissues, including mesenteric, epididymal, and subcutaneous, was analyzed by qRT-PCR. These adipose tissues were also examined for histological evidence of inflammation. The level of cytokine mRNA during acute colitis was compared between mature mesenteric adipocytes, mesenteric stromal vascular fraction (SVF), and mesenteric lymph nodes. RESULTS: During acute colitis, MAT exhibited an increased presence of infiltrating mononuclear cells and fibrotic structures, as well as decreased adipocyte size. The mRNA levels of TNF-α, IL-1β, and IL-6 were significantly increased in MAT but not other adipose tissue depots. Within the MAT, induction of these cytokines was observed mainly in the SVF. CONCLUSIONS: Acute experimental colitis causes a strong site-specific inflammatory response within MAT, which is mediated by cells of the SVF, rather than mature adipocytes or mesenteric lymph nodes

The globalizability of temporal discounting

Economic inequality is associated with preferences for smaller, immediate gains over larger, delayed ones. Such temporal discounting may feed into rising global inequality, yet it is unclear whether it is a function of choice preferences or norms, or rather the absence of sufficient resources for immediate needs. It is also not clear whether these reflect true differences in choice patterns between income groups. We tested temporal discounting and five intertemporal choice anomalies using local currencies and value standards in 61 countries (N = 13,629). Across a diverse sample, we found consistent, robust rates of choice anomalies. Lower-income groups were not significantly different, but economic inequality and broader financial circumstances were clearly correlated with population choice patterns